**Author details**

Ayotunde Oladunni Ale Department of Medicine, Obafemi Awolowo College of Health Sciences, Faculty of Clinical Sciences, Olabisi Onabanjo University, Sagamu campus, Ogun State, Nigeria

\*Address all correspondence to: ayoale2004@yahoo.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**121**

Mar 4

*Thyroid Disorders and Osteoporosis*

**References**

2012;**8**:674-683

2017;**25**:218

*DOI: http://dx.doi.org/10.5772/intechopen.87129*

[10] Nicholls JJ, Brassill MJ, Williams GR, Bassett JH. The skeletal consequences of thyrotoxicosis. The Journal of Endocrinology. 2012;**213**:209-221. DOI: 10.1530/JOE-12-0059. Epub 2012 Mar 27

[11] Tuchendler D, Bolanowski M. The influence of thyroid dysfunction on bone metabolism. Thyroid Research. 2014;**7**:12. DOI: 10.1186/s13044-014-

[12] Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clinic Proceedings.

[13] Cardoso LF, Maciel LM, Paula FJ. The multiple effects of thyroid disorders on bone and mineral metabolism. Arquivos Brasileiros de Endocrinologia e

[14] Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocrine Reviews. 2014;**35**:433-512. DOI: 10.1210/

Metabologia. 2014;**58**:452-463

er.2013-1083. Epub 2014 Jan 16

0042. Epub 2009 Jun 18

2006;**116**:2571-2579

[15] Van der Deure WM, Peeters RP, Visser TJ. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. Journal of Molecular Endocrinology. 2010;**44**(1):1-11. DOI: 10.1677/JME-09-

[16] Bianco AC, Kim BW. Deiodinases: Implications of the local control of thyroid hormone action. The Journal of Clinical Investigation.

[17] Williams GR, Bassett JHD. Thyroid diseases and bone health. Journal of Endocrinological Investigation. 2018;**41**:99-109. DOI: 10.1007/s40618-

[18] Freitas FR, Moriscot AS, Jorgetti V, Soares AG, Passarelli M, Scanlan TS, et al. Spared bone mass in rats treated

017-0753-4. Epub 2017 Aug 29

0012-0. eCollection 2014

2002;**77**:453-468

[1] Clarke B. Normal bone anatomy and physiology. Clinical Journal of the American Society of Nephrology: CJASN. 2008;**3**(Suppl 3):S131-S139

Farquharson C. Endocrine role of bone: Recent and emerging perspectives beyond osteocalcin. Journal of Endocrinology. 2015;**225**:R1-R19

Kousteni S. The skeleton as an endocrine organ. Nature Reviews Rheumatology.

[2] Oldknow KJ, MacRae VE,

[3] DiGirolamo DJ, Clemens TL,

[4] Mera P, Laue K, Ferron M, et al. Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metabolism.

[5] Mosialou I, Shikhel S, Liu JM, et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2.

Nature. 2017;**543**:385-390

2006;**354**:2250-2261

[6] Seeman E, Delmas PD. Bone quality: The material and structural basis of bone strength and fragility. New England Journal of Medicine.

[7] Manolagas SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews. 2000;**21**:115-137

[8] Kenkre JS, Bassett J. The bone remodelling cycle. Annals of Clinical Biochemistry. 2018;**55**:308-327. DOI: 10.1177/0004563218759371. Epub 2018

[9] Katsimbri P. The biology of normal bone remodelling. European Journal of Cancer Care. 2017;**26**:e12740. Available from: https://onlinelibrary.wiley.com/ doi/10.1111/ecc.12740. DOI: 10.1111/

ecc.12740. Epub 2017 Aug 8
